Status:
COMPLETED
The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
Lead Sponsor:
Jun Zhang
Collaborating Sponsors:
Liuzhou center of disease prevention and control
Conditions:
Human Papillomavirus Infection
Genital Warts
Eligibility:
All Genders
18-55 years
Brief Summary
primary purpose:Evaluate the prevalence and incidence of HPV infection and related diseases in subjects. Secondary purpose:Analyze risk factors of HPV infection and related diseases.
Eligibility Criteria
Inclusion
- ages 18 to 55 years;
- residents of the study site;
- at least one sex partner;
- Be able to understand and comply with the request of the protocol.
Exclusion
- pregnant;
- has received HPV vaccines.
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
4691 Patients enrolled
Trial Details
Trial ID
NCT02188004
Start Date
June 1 2014
End Date
May 1 2016
Last Update
May 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liuzhou Center of disease prevention and control
Liuchow, Guangxi, China